Prescription drug · NDA
Zemplar (Paricalcitol) NDC 0074-9037
Paricalcitol 2 ug/1 · Capsule, Liquid filled · Oral · AbbVie Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0074-9037-30 | 00074903730 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-9037-30)Marketed from Apr 20, 2018 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zemplar
- Generic name (nonproprietary)
- paricalcitol
- Active ingredients
- Paricalcitol — 2 ug/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Labeler
- AbbVie Inc.NDC labeler code 0074
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021606
- Marketing start
- Marketing end
- Other FDA classes
- Ergocalciferols (Chemical structure)
- Identifiers
- Product ID 0074-9037_61ef39c0-0c32-4b82-962e-8ebdd55ce427SPL ID 61ef39c0-0c32-4b82-962e-8ebdd55ce427SPL set ID 1b27c026-2d60-47b4-2a9c-ded1818f21b5RxCUI 577315, 577317, 606854, 606859UNII 6702D36OG5UPC 0300749036309, 0300749037306
- Pharmacologic class
- Vitamin D Analog; Vitamin D2 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400074903730followed by a unit qualifier and the quantityPackage 00074-9037-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ZEMPLAR is a vitamin D analog indicated in adults and pediatric patients 10 years and older for the prevention and treatment of secondary hyperparathyroidism associated with: Chronic kidney disease (CKD) Stages 3 and 4 ( 1.1 ). CKD Stage 5 in patients on hemodialysis or peritoneal dialysis ( 1.2 ). 1.1 Chronic Kidney Disease Stages 3 and 4 ZEMPLAR capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. 1.2 Chronic Kidney Disease Stage 5 ZEMPLAR capsules are indicated in adults and pediatric patients 10 years of age and older for the preventi…
Excerpt only. Read the full label for complete information.
About NDC 0074-9037
- What is NDC 0074-9037?
- 0074-9037 is the product NDC for Zemplar (paricalcitol), Paricalcitol 2 ug/1 capsule, liquid filled, listed with the FDA by AbbVie Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zemplar (Paricalcitol).
- What is the active ingredient?
- Paricalcitol.
- Who is the labeler?
- AbbVie Inc., NDC labeler code 0074. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zemplar?
- 3 other product NDCs are listed under this name. See all Zemplar NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zemplar products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zemplarparicalcitol | Paricalcitol 1 ug/1 | Capsule, Liquid filledOral | AbbVie Inc. | 0074-9036 | 00074-9036-30 |
| Zemplarparicalcitol | Paricalcitol 2 ug/mL | Injection, SolutionIntravenous | AbbVie Inc. | 0074-4637 | 00074-4637-01 |
| Zemplarparicalcitol | Paricalcitol 5 ug/mL | Injection, SolutionIntravenous | AbbVie Inc. | 0074-1658 | 00074-1658-0100074-1658-05 |
Other NDCs under NDA 021606
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zemplarparicalcitol | Paricalcitol 1 ug/1 | Capsule, Liquid filledOral | AbbVie Inc. | 0074-9036 |